Learn Before
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology
People with diabetes mellitus are among those with the highest risk of COVID-19 infection related complications as chronic hyperglycemia has a negative impact on immune function and increases the risk of morbidity and mortality with any infections. This was was evident with the H1N1 pandemic in which diabetes tripled the risk of ICU admissions when hospitalized. Around February 2020, diabetes accounted for 42.3% of major comorbidities in COVID-19 cases in Wuhan, China. A mortality of 7.3% was also reported for people with diabetes. Due to likeliness of people with diabetes to experience a deterioration of glycemic control when infected with COVID-19, it is essential for people with diabetes to contact their healthcare providers for advice an avoiding a loss of control over their diabetes.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
COVID-19 and diabetes: Knowledge in progress
The Link Between Diabetes and ACE2
Diabetes in COVID-19 Patients by Geographic Location
Diabetes Mellitus and a study of its Epidemiology in relation to COVID-19
The effect of hyperglycemia in relation ot COVID-19
Degree of Hyperglycemia on COVID-19 Mortality
Diabetes Medication on COVID-19 Mortality
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology
How Elevated Glucose Levels Favor SARS-CoV-2 Infection?